These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
394 related articles for article (PubMed ID: 35204770)
1. Advances in Ophthalmic Optogenetics: Approaches and Applications. Prosseda PP; Tran M; Kowal T; Wang B; Sun Y Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204770 [TBL] [Abstract][Full Text] [Related]
2. Optogenetic Therapy for Visual Restoration. Sakai D; Tomita H; Maeda A Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499371 [TBL] [Abstract][Full Text] [Related]
4. Optogenetics for visual restoration: From proof of principle to translational challenges. Lindner M; Gilhooley MJ; Hughes S; Hankins MW Prog Retin Eye Res; 2022 Nov; 91():101089. PubMed ID: 35691861 [TBL] [Abstract][Full Text] [Related]
5. Optogenetic Strategies for Vision Restoration. Lu Q; Pan ZH Adv Exp Med Biol; 2021; 1293():545-555. PubMed ID: 33398841 [TBL] [Abstract][Full Text] [Related]
6. Degenerated Cones in Cultured Human Retinas Can Successfully Be Optogenetically Reactivated. Kamar S; Howlett MHC; Klooster J; Graaff W; Csikós T; Rabelink MJWE; Hoeben RC; Kamermans M Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947650 [TBL] [Abstract][Full Text] [Related]
7. Optogenetic approaches to therapy for inherited retinal degenerations. De Silva SR; Moore AT J Physiol; 2022 Nov; 600(21):4623-4632. PubMed ID: 35908243 [TBL] [Abstract][Full Text] [Related]
8. Optogenetic Stimulation for Restoring Vision to Patients Suffering From Retinal Degenerative Diseases: Current Strategies and Future Directions. Montazeri L; El Zarif N; Trenholm S; Sawan M IEEE Trans Biomed Circuits Syst; 2019 Dec; 13(6):1792-1807. PubMed ID: 31689206 [TBL] [Abstract][Full Text] [Related]
9. An Engineering Platform for Clinical Application of Optogenetic Therapy in Retinal Degenerative Diseases. Yan B; Nirenberg S IEEE J Transl Eng Health Med; 2023; 11():296-305. PubMed ID: 37250684 [TBL] [Abstract][Full Text] [Related]
10. Cellular and subcellular optogenetic approaches towards neuroprotection and vision restoration. Wood EH; Kreymerman A; Kowal T; Buickians D; Sun Y; Muscat S; Mercola M; Moshfeghi DM; Goldberg JL Prog Retin Eye Res; 2023 Sep; 96():101153. PubMed ID: 36503723 [TBL] [Abstract][Full Text] [Related]
11. Opsins for vision restoration. Simon CJ; Sahel JA; Duebel J; Herlitze S; Dalkara D Biochem Biophys Res Commun; 2020 Jun; 527(2):325-330. PubMed ID: 31982136 [TBL] [Abstract][Full Text] [Related]
12. Restoration of Vision and Retinal Responses After Adeno-Associated Virus-Mediated Optogenetic Therapy in Blind Dogs. Nikonov S; Aravand P; Lyubarsky A; Nikonov R; Luo AJ; Wei Z; Maguire AM; Phelps NT; Shpylchak I; Willett K; Aleman TS; Huckfeldt RM; Ramachandran PS; Bennett J Transl Vis Sci Technol; 2022 May; 11(5):24. PubMed ID: 35604672 [TBL] [Abstract][Full Text] [Related]
14. A light in the dark: state of the art and perspectives in optogenetics and optopharmacology for restoring vision. Chemi G; Brindisi M; Brogi S; Relitti N; Butini S; Gemma S; Campiani G Future Med Chem; 2019 Mar; 11(5):463-487. PubMed ID: 30907134 [TBL] [Abstract][Full Text] [Related]
15. Optogenetic approaches to vision restoration. Simunovic MP; Shen W; Lin JY; Protti DA; Lisowski L; Gillies MC Exp Eye Res; 2019 Jan; 178():15-26. PubMed ID: 30218651 [TBL] [Abstract][Full Text] [Related]
16. Retinal optogenetic therapies: clinical criteria for candidacy. Jacobson SG; Sumaroka A; Luo X; Cideciyan AV Clin Genet; 2013 Aug; 84(2):175-82. PubMed ID: 23590195 [TBL] [Abstract][Full Text] [Related]